Cochrane Clinical Answers - Access Denied - How does two-weekly administration of erythropoiesis-stimulating agents compare with weekly and monthly administration for people with anemia due to chronic kidney disease who are not on dialysis?

Question:How does two-weekly administration of erythropoiesis-stimulating agents compare with weekly and monthly administration for people with anemia due to chronic kidney disease who are not on dialysis?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer compares two-weekly administration of erythropoiesis-stimulating agents versus weekly and monthly administration for people with anemia due to chronic kidney disease who are not on dialysis.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.